AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 15 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 4.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $8,351,000 | -10.5% | 12,460,000 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $9,329,000 | -0.1% | 12,460,000 | 0.0% | 0.01% | +66.7% |
Q3 2018 | $9,336,000 | +15.5% | 12,460,000 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $8,086,000 | -16.5% | 12,460,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $9,687,000 | -2.2% | 12,460,000 | 0.0% | 0.00% | -20.0% |
Q4 2017 | $9,906,000 | -0.4% | 12,460,000 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $9,948,000 | -0.3% | 12,460,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $9,973,000 | -1.5% | 12,460,000 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $10,130,000 | -0.0% | 12,460,000 | -12.0% | 0.01% | -16.7% |
Q4 2016 | $10,131,000 | +27.2% | 14,160,000 | +17.4% | 0.01% | +50.0% |
Q3 2016 | $7,962,000 | +17.2% | 12,060,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $6,796,000 | -25.0% | 12,060,000 | -33.2% | 0.00% | -20.0% |
Q1 2016 | $9,063,000 | -55.3% | 18,060,000 | -40.8% | 0.01% | -58.3% |
Q4 2015 | $20,266,000 | -16.2% | 30,490,000 | -4.3% | 0.01% | -20.0% |
Q3 2015 | $24,176,000 | – | 31,870,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
CSS LLC/IL | 653,000 | $517,000 | 0.02% |
Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |